Triazolam Tablet
Product Images NDC 70710-1521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 70710-1521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (966203bd 22b3 4bbb 9c35 7e7ba557a37a 01)

FDA Label Image

Image (966203bd 22b3 4bbb 9c35 7e7ba557a37a 02)

Image (966203bd 22b3 4bbb 9c35 7e7ba557a37a 02)
This is a medication label for Triazolam tablets, USP. Each tablet contains 0.125 mg of the medication. The label includes dosage instructions, storage information, and a warning to keep medication out of reach of children. It was manufactured by Cadila Healthcare Lic. in India and distributed by Zydus Pharmaceuticals (USA) Inc.*
FDA Label Image

Image (966203bd 22b3 4bbb 9c35 7e7ba557a37a 03)

Image (966203bd 22b3 4bbb 9c35 7e7ba557a37a 03)
This is a medication label for Triazolam tablets, USP. It includes the manufacturer's information, dosage instructions, and a warning to keep the drug out of reach of children. It's distributed by Zydus Pharmaceuticals in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.